A Cost Minimization Comparison of Two Surfactants—Beractant and Poractant alfa—Based Upon Prospectively Designed, Comparative Clinical Trial Data

Por Marsh, Wallace, Smeeding, James, York, John M., Ramanathan, Rangasamy, Sekar, Krishnamurthy
Publicado em 2004

Pharmacoeconomics of Surgical Interventions vs. Cyclooxygenase Inhibitors for the Treatment of Patent Ductus Arteriosus

Por Turck, Charles J, Marsh, Wallace, Stevenson, James G., York, John M., Miller, Henry, Patel, Snehal
Publicado em 2007

An Open Label Comparison of Calfactant and Poractant Alfa Administration Traits and Impact on Neonatal Intensive Care Unit Resources

Por Gerdes, Jeffrey S., Seiberlich, William, Sivieri, Emidio M., Marsh, Wallace, Varner, Dwight L., Turck, Charles J, York, John M.
Publicado em 2006